Pathology Market Report 2024 (Global Edition)

Global Pathology Market Report 2024 Market Size Split by Product (Scanners, Software, Communication Systems, Storage Systems, Instruments, Consumables, Services), by Type (Human Digital Pathology, Ani...

Pathology Market Report Description

We have various report editions of Pathology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Pathology Market

The market under study has a modest degree of fragmentation. The market has grown more rapidly as a result of continued R&D efforts to produce cutting-edge technologies and product innovation. Product development, company growth, and cooperative development are among the tactics used. In order to broaden their individual product portfolios and have a strong presence in the worldwide market, big businesses are also involved in product creation and strategic partnerships.

Top Companies Market Share in Pathology Industry: (In no particular order of Rank)

• Omnyx LLC
• Koninklijke Philips N V
• Hamamatsu Photonics K K
• GE Healthcare
• Ventana Medical Systems Inc
• microDimensions GmbH
• Leica Biosystems Nussloch GMBH
• Apollo Enterprise Imaging Corporation
• Mikroscan Technologies Inc
• Huron Digital Pathology Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Pathology Market

Which Region will Dominate the Pathology  Market in 2024?

According to Cognitive Market Research, North America dominated the pathology market in 2024 and accounted for around 40% of the global revenue. The increasing burden of chronic diseases, the expanding use of technology in managing chronic diseases, rising investments, rising product releases, and the actions taken by major market players are the main drivers propelling the expansion of the North American pathology market. Additionally, tactics like growing alliances, market development, and increased investments by significant companies would encourage innovation in the area and thus expand the market.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific is anticipated to be the fastest-growing region in the pathology market in the forecast period. It is predicted that the growing number of healthcare chains collaborating with important businesses to handle the rising number of tests in diagnostic labs would support regional market expansion. Furthermore, the adoption of digital tools and solutions among key stakeholders is fast due to significant expenditures made by both public and private institutions, as well as an expanding healthcare infrastructure. 

The current report Scope analyzes Pathology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Pathology Market

According to Cognitive Market Research, the global pathology market size was estimated at USD XX Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Innovations like digital pathology and AI-driven diagnostics, which increase diagnosis accuracy and efficiency, are important examples of technological developments. In addition, the need for pathology services is fueled by the rising prevalence of chronic diseases including cancer and cardiovascular disorders, which is propelling market expansion. Furthermore, the aging of the North American population drives up the cost of disease diagnostic tests because age-related illnesses necessitate a thorough pathological assessment in order to plan successful treatments. The need for pathology services is also being driven by the increased understanding of early disease identification and tailored medication among patients and healthcare professionals. 

• According to Cognitive Market Research, the US had a major share in the pathology market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 6.2% during the forecast period. The need for pathology solutions in this nation has been further spurred by the rise in cancer prevalence and the desire for tailored medicine.
• The Canada pathology market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period because of the growing need for effective and precise diagnostic tools, developments in imaging technologies, and the increased frequency of long-term illnesses, particularly cancer.
• The Mexico pathology market is projected to witness growth at a CAGR of 6.9% during the forecast period with a market size of USD XX million in 2024.

 

Europe Pathology Market

According to Cognitive Market Research, with a market value of USD XX million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD XX million because to a number of variables, including the development of technology, the rise in chronic illness, and the need for customized treatment. There has been a noticeable movement toward more effective diagnostic methods and remote consulting services with the introduction of digital pathology. The accuracy and speed of pathological analyses have also improved with the incorporation of artificial intelligence and machine learning algorithms, which has further fueled industry expansion. Additionally, it is anticipated that academic and government research institute attempts to enhance healthcare infrastructure and raise public knowledge of preventative healthcare measures will maintain the growth momentum in the European pathology market.

• The United Kingdom pathology market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. The country's market is growing because of the growing number of elderly people and the rising incidence of chronic illnesses.
• The France pathology market is projected to witness growth at a CAGR of 5.9% during the forecast period with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the Germany pathology market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.9% during the forecast period because of the rise in the number of medical facilities in emerging countries and the rising need for regular checkups.
• The Italy pathology market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD XX million in 2024.
• The Russia pathology market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD XX million in 2024.
• The Spain pathology market is projected to witness growth at a CAGR of 5.8% during the forecast period with a market size of USD XX million in 2024.
• The Luxembourg pathology market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD XX million in 2024.
• The Portugal pathology market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD XX million in 2024.
• The Greece pathology market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD XX million in 2024.
• Rest of Europe pathology market is projected to witness growth at a CAGR of 5.4% during the forecast period with a market size of USD XX million in 2024.

Asia Pacific Pathology Market

According to Cognitive Market Research, the global Pathology market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031 influenced by a number of variables, including rising healthcare costs, the incidence of chronic illnesses, and improvements in diagnostic technology. Government programs to enhance healthcare accessibility and infrastructure have also stimulated industry growth. The pathology industry is expanding quickly in nations like China, India, Japan, and South Korea, where an increasing number of labs and diagnostic centers are opening up to meet the expanding healthcare demands of their populace. Furthermore, partnerships among healthcare providers, pharmaceutical companies, academic institutions, and industry participants are stimulating innovation and propelling the use of state-of-the-art diagnostic solutions. 

• According to Cognitive Market Research, the China pathology market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 9.7% during the forecast period. The increasing incidence of cancer in this country and the demand for personalized treatment have further increased the need for pathology solutions.
• The Japan pathology market is projected to witness growth at a CAGR of 8.7% during the forecast period with a market size of USD XX million in 2024.
• The India pathology market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 12.0% during the forecast period. The aging population and the increase in chronic ailments are driving growth in the country's market.
• The South Korea pathology market is projected to witness growth at a CAGR of 9.3% during the forecast period with a market size of USD XX million in 2024.
• The Australia pathology market is projected to witness growth at a CAGR of 9.9% during the forecast period with a market size of USD XX million in 2024.
• The South East Asia pathology market is projected to witness growth at a CAGR of 11.2% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Asia Pacific pathology market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD XX million in 2024.

 

South America Pathology Market

According to Cognitive Market Research, the global Pathology market size was estimated at USD XX Million out of which Latin America market of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031. The rising incidence of chronic illnesses including diabetes, cancer, and cardiovascular disease throughout the region is one important contributing cause. The need for pathology services, such as diagnosis, illness monitoring, and treatment planning, has increased dramatically as these diseases grow more common. Furthermore, improvements in healthcare infrastructure and medical technology have raised the caliber and accessibility of pathology services in Latin America. Moreover, the region's pathology industry has grown as a result of government and healthcare organization initiatives to support early disease diagnosis and management. 

• According to Cognitive Market Research, the Brazil pathology market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 8.2% during the forecast period due to the increased prevalence of chronic illnesses, especially cancer, the advancements in imaging technologies, and the growing need for accurate and efficient diagnostic tools.
• The Argentina pathology market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period due to the expansion of healthcare facilities in developing nations and the growing demand for routine examinations.
• The Colombia pathology market is projected to witness growth at a CAGR of 7.4% during the forecast period with a market size of USD XX million in 2024.
• The Peru pathology market is projected to witness growth at a CAGR of 7.8% during the forecast period with a market size of USD XX million in 2024.
• The Chile pathology market is projected to witness growth at a CAGR of 7.9% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Latin America pathology market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD XX million in 2024.

Middle East and Africa Pathology Market

According to Cognitive Market Research, the global Pathology market size was estimated at USD XX Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. This region's market is developing because of things like expanding healthcare infrastructure, an increase in the prevalence of chronic diseases, and technological improvements. The growth of pathology services in the Middle East and Africa is also facilitated by initiatives to enhance healthcare quality and accessibility. Additionally, governments and private investors are contributing more to the construction of hospitals, clinics, and other healthcare facilities. The extension of pathology services throughout the region is facilitated by this infrastructure development. Some Middle Eastern nations, including Saudi Arabia and the United Arab Emirates, have developed into centers of medical tourism, drawing travelers from nearby areas and other countries in search of cutting-edge medical care, including pathology services.

• According to Cognitive Market Research, the GCC Countries pathology market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period. The need for pathology solutions has grown as a result of the rising cancer incidence in this nation and the desire for individualized care.

• The Egypt pathology market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD XX million in 2024.
• The South Africa pathology market is projected to witness growth at a CAGR of 8.9% during the forecast period with a market size of USD XX million in 2024. The country's market is expanding due to the aging population and rise in chronic illnesses.
• The Turkey pathology market is projected to witness growth at a CAGR of 7.4% during the forecast period with a market size of USD XX million in 2024.
• The Nigeria pathology market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD XX million in 2024.
• The Rest of MEA pathology market is projected to witness growth at a CAGR of 6.9% during the forecast period with a market size of USD XX million in 2024.

Pathology Market Analysis

Pathology Market Product Segment Analysis

According to Cognitive Market Research, consumables category held the major market share over the forecast period. The extensive availability and reasonable cost of pathology consumables are two of the elements contributing to this segment's prominence. In addition, the wide availability of a wide variety of items in this market category contributes to the market's expansion. 

Instruments is the fastest-growing category over the forecast period. It is expected that the instruments segment would increase more quickly due to ongoing technological innovation and market participants' persistent attempts to offer anatomic pathology equipment with cutting-edge designs.

• Scanners
• Software
• Communication Systems
• Storage Systems
• Instruments
• Consumables
• Services

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Pathology Industry. Request a Free Sample PDF!

Pathology Market Type Segment Analysis

According to Cognitive Market Research, human digital pathology category held a prominent market share driven by the development of technology and the growing need for diagnostic instruments with higher levels of accuracy. With the use of digital pathology, pathologists can view and examine tissue samples from a distance by digitizing conventional glass slides. This leads to better accurate diagnosis and treatment strategies by improving communication among medical professionals and increasing efficiency through the streamlining of workflow operations. 

Animal digital pathology is the fastest-growing category over the forecast period. Digital pathology solutions designed exclusively for animals have gained traction due to technological improvements and the growing demand in veterinary practice for accurate diagnostic tools. With the use of these technologies, veterinarians can now diagnose patients, create treatment regimens, and test tissue samples with accuracy and accessibility from a distance. 

• Human Digital Pathology
• Animal Digital Pathology

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Pathology Application Segment Analysis

According to Cognitive Market Research, disease diagnosis category held a prominent market share. Pathology is essential to the diagnosis of disease and provides researchers with a means of investigating the causes of disease and its consequences. As a result, the industry is witnessing a significant upswing in the general use of pathology procedures for illness diagnosis.

Durg discovery & development is the fastest-growing category over the forecast period. During preclinical studies, pharmaceutical makers benefit greatly from the quantity of information generated by pathologists' tissue examination. In toxicological assessment, pathology is essential for assessing the side effects of potential medications. 

• Disease Diagnosis
• Teleconsultation
• Drug Discovery & Development
• Training & Education
• Others

Pathology End User Segment Analysis

According to Cognitive Market Research, pharmaceutical category held a prominent market share because of aging populations, rising rates of chronic illnesses, improved medical technology, and an increased emphasis on customized treatment. The need for pathology services including diagnostic testing and molecular analysis is being driven by pharmaceutical companies' constant development of new medications and treatments for a range of illnesses.

The academic & government research institutes are the fastest-growing category over the forecast period. Pathology is a vital tool in the research endeavors of academic & government research institutions, which are fundamental to the advancement of medical knowledge and the comprehension of pathology. Academic researchers can benefit from a number of advantages provided by pathology, including the capacity to digitize and store large collections of tissue samples, which makes data exchange and access easier between researchers globally. 

• Pharmaceutical
• Biotechnology Companies and CROs
• Hospitals & Reference Laboratories
• Academic & Government Research Institutes

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion